Key result
Surgical resection of cardiac myxomas yields low perioperative mortality and low sporadic recurrence.
Why the study?
Primary cardiac tumours are rare, and surgical treatment decisions for myxomas are made to prevent thromboembolism and valvular obstruction.
Answers are grounded in this paper and cite their sources.
Surgical resection of myxomas remains appropriate to avert complications; Level 5 data leaves open need for prospective outcome studies.
According to unselected autopsy data, primary cardiac tumours are a rare entity. About 80% of the tumours are benign and nearly half of these are myxomas. In clinical practice, when diagnosis of this pathological entity is ascertained, decision for surgical treatment is made in order to prevent thromboembolism and obstruction of the valvular apparatus. Surgical resection including total tumour removal is accompanied by low perioperative mortality. The recidive rate is low in sporadic cases. However, in familial syndrome groups, such as the Swiss-Carney syndrome, the recurrence rate is higher.
No takes yet. Share an insight, caveat, or question.
Berdajs et al. (2012) conducted a review in Heart myxomas. Surgical resection was evaluated on Perioperative mortality and recurrence rate. Surgical resection of heart myxomas is accompanied by low perioperative mortality and a low recurrence rate in sporadic cases, though recurrence is higher in familial syndromes.
Synapse has enriched 10 related papers. Consider them for comparative context: